Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2021 Earnings Conference Call May 5, 2021 8:30 AM ET Company Participants Thomas Cowhey - Executive Vice President and Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies LLC Kevin Fischbeck - Bank of America Merrill Lynch Ralph Giacobbe - Citigroup Inc. William Sutherland - The Benchmark Company, LLC Frank Morgan - RBC Capital Markets Operator Greetings, welcome to Su ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ Form 10-Q _____________________________________ or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37576 _____________________________________ Surgery Partners, Inc. (Exact name of registrant as specified in its charter) _____________________________________ (State or other jurisdiction of incorporation or organization) 310 Seven ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________ Form 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020 OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-37576 Surgery Partners, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2020 Earnings Conference Call March 10, 2021 8:30 AM ET Company Participants Tom Cowhey - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Frank Morgan - RBC Ralph Giacobbe - Citi Operator Greetings, and welcome to Surgery Partners Fourth Quarter and Year-End 2020 Earnings Conference Call. At this time, all participants are in a lis ...

╬ SURGERY PARTNERS 39th Annual J.P. Morgan Healthcare Conference IIIIIIIIIIIIIII Legal Disclaimer Forward-Looking Statements Statements contained in this presentation, including the question and answer portion of the presentation, other than statements of historical fact, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "predicts," "pot ...

Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2020 Earnings Conference Call November 4, 2020 8:30 AM ET Company Participants Tom Cowhey - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Frank Morgan - RBC Capital Markets Bill Sutherland - The Benchmark Company Brian Tanquilut - Jefferies Operator Greetings and welcome to the Surgery Partners' Third Quarter 2020 Earnings Call. At this time, all participants are in a listen-only mode. A qu ...

Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2020 Results Earnings Conference Call August 5, 2020 8:30 AM ET Company Participants Tom Cowhey - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Kevin Fischbeck - Bank of America Brian Tanquilut - Jefferies Operator Greetings. And welcome to the Surgery Partners, Inc. Second Quarter 2020 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session wi ...

Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Wayne DeVeydt - Executive Chairman Thomas Cowhey - CFO Eric Evans - CEO Conference Call Participants Kevin Fischbeck - Bank of America Merrill Lynch Ralph Giacobbe - Citigroup Brian Tanquilut - Jefferies Frank Morgan - RBC Whit Mayo - UBS Operator Good afternoon, and welcome to the Surgery Partners, Inc. First Quarter 2020 Earnings Call. [Operator Instructions] I would now like to turn the conf ...

Financial Data and Key Metrics Changes - Full-year adjusted EBITDA reached $258.6 million, representing a growth of 10.1% over 2018 [13] - Adjusted revenues for the fourth quarter grew 4.2% to $520.7 million, while full-year adjusted revenues rose to $1.86 billion, reflecting nearly 3% year-over-year growth [28][30] - Adjusted EBITDA margin improved to 16.2% in the fourth quarter from 14.7% in the prior year period, and full-year adjusted EBITDA margin increased by 90 basis points to 13.9% [31] Business Line Data and Key Metrics Changes - Same facility revenue growth was nearly 8% year-over-year, with fourth-quarter adjusted same facility revenue increasing by 7.9% [9][14] - Approximately 138,000 surgical cases were performed in the fourth quarter, ending the year with around 525,000 cases [27] - The company reported strong growth in higher acuity cases, with about 1,300 total joint procedures performed in 2019, nearly double the total from 2018 [18] Market Data and Key Metrics Changes - The company achieved double-digit commercial rate increases in multiple markets, contributing to fourth-quarter net revenue per case growth [19] - The company expects its base business to grow at a long-term sustainable rate of 2% to 3% on volume and 2% to 3% on rate, yielding 4% to 6% same facility revenue growth [20] Company Strategy and Development Direction - The company is focused on physician recruiting, managed care, procurement, and revenue cycle management to differentiate itself as the operator of choice [8] - The company is actively pursuing a robust pipeline of tuck-in acquisitions and expects to see increased opportunities for acquisitions at attractive multiples in 2020 [10][11] - The company aims to expand its capabilities in multi-specialty centers, particularly in total joint procedures, with a goal of increasing the percentage of centers performing these procedures [18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit adjusted EBITDA growth for both the immediate and long-term future [9] - The company has not yet seen any impact from the coronavirus on its operations, but is taking precautions to ensure safety [43] - Management anticipates continued strong same facility revenue growth and margin expansion as strategic initiatives take hold [41] Other Important Information - The company opened a new hospital in Idaho Falls in November 2019, which is expected to be a material contributor to adjusted EBITDA in the coming years [33][34] - The company ended 2019 with a cash balance of approximately $93 million and no borrowings on its revolving credit facility [33] Q&A Session Summary Question: Impact of coronavirus on operations - Management stated that there has been no impact from the coronavirus to date, but they are monitoring the situation closely [43] Question: Cash flow expectations for 2020 - Management noted that higher interest expenses and startup costs for the Idaho Falls hospital impacted cash flow, but they expect to grow double-digit earnings in 2020 [44][47] Question: M&A outlook and potential deals - Management confirmed a robust M&A pipeline and expects to announce more transactions in 2020 than in the previous year [51][65] Question: Physician recruitment and volume ramp-up - Management anticipates a slight increase in physician recruitment numbers in 2020 compared to previous years, with a focus on targeted specialties [55] Question: Total joint procedures and market expansion - Management indicated that they expect to increase the number of facilities capable of performing total joint procedures, with minimal capital requirements for many of these expansions [86]

38th Annual J.P. Morgan Healthcare Conference January 13, 2020 © 2020 Surgery Partners – Confidential & Proprietary Information Legal disclaimer Forward-Looking Statements Statements contained in this presentation, including the question and answer portion of the presentation, other than statements of historical fact, are forwardlooking statements. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believ ...